Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.01%
SPX
-0.34%
IXIC
-0.75%
FTSE
-0.43%
N225
-1.16%
AXJO
-0.14%
Cashu Logo
⌘K
Log In
HomeWatchlistNewsSignals
Stocks
Health Care
mtva
MetaVia
NASDAQ: MTVA
-0.02 (-1.24%)
1.59
USD
At close at Mar 13, 18:40 UTC
Summary
News
Signals
Benchmarks
Financials

Overview

Loading chart...

Key Stats

Market Cap
3.54M
Dividend Yield
0.00%
P/E Ratio
-0.22
EPS
-44.40
Revenue
-
Avg. Volume
130.10K

Recently from Cashu

publisher logo
Cashu

MetaVia Strengthens IP Portfolio for Innovative Cardiometabolic Disease Solutions with Vanoglipel

about 7 hours ago
publisher logo
Cashu

MetaVia Expands IP Portfolio to Enhance Treatment of Metabolic Diseases with Vanoglipel

2 days ago
publisher logo
Cashu

MetaVia Advances Innovative Therapies for Cardiometabolic Diseases Ahead of Investor Forum

7 days ago

About

What does MTVA do?
NeuroBo Pharmaceuticals, based in Cambridge, Massachusetts, develops multi-modal therapies, including DA-1241 for MASH and Type 2 Diabetes, and DA-1726 for obesity. The company went public on August 5, 2016.
Sector
💻 Health Care
IPO
CEO
Employees
9
Headquarters
Massachusetts, USA
Website
http://www.neurobopharma.com
Join our newsletter to keep up to date with us!
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.